Share class: Guided Therapeutics Inc

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A196,537,34961,284,511 ( 63.48 %) 0 63.48 %
Stock B030000
Stock C040000
Stock D010000
Stock E020000

Major shareholders: Guided Therapeutics Inc

NameStocks%Valuation
22.01 %
21,252,673 22.01 % 6 M $
10.76 %
10,391,311 10.76 % 3 M $
GPB Capital Holdings LLC
9.463 %
9,135,152 9.463 % 3 M $
4.997 %
4,824,361 4.997 % 1 M $
Auctus Fund Management LLC
4.401 %
4,248,474 4.401 % 1 M $
Flynn Case D Living Trust
3.643 %
3,517,319 3.643 % 1 M $
2.349 %
2,267,551 2.349 % 680 265 $
1.883 %
1,817,541 1.883 % 545 262 $
DRG Services LLC
1.833 %
1,769,231 1.833 % 530 769 $
K2 Medical LLC
0.8378 %
808,836 0.8378 % 242 651 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameStocks%Valuation
K2 Medical LLC
42.88 %
440 42.88 % 132 $
Auctus Fund Management LLC
19.49 %
200 19.49 % 60 $
NameStocks%Valuation
8.676 %
38 8.676 % 11 $
NameStocks%Valuation
Auctus Fund Management LLC
11.89 %
105 11.89 % 32 $
NameStocks%Valuation
18.65 %
97 18.65 % 29 $

Breakdown by shareholder type

Individuals42.68%
Institutional13.86%
Others6.31%
Unknown37.14%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
42.68%
United States
20.18%

Based on 1000 largest holdings

Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-